The store will not work correctly when cookies are disabled.
5-bromo-3-[1-methylcyclopropyl]amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide
ID: ALA210210
PubChem CID: 135508259
Max Phase: Preclinical
Molecular Formula: C9H10BrN3O2S2
Molecular Weight: 336.24
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(NC2=NS(=O)(=O)c3scc(Br)c3N2)CC1
Standard InChI: InChI=1S/C9H10BrN3O2S2/c1-9(2-3-9)12-8-11-6-5(10)4-16-7(6)17(14,15)13-8/h4H,2-3H2,1H3,(H2,11,12,13)
Standard InChI Key: LVGINCMFJCKGQA-UHFFFAOYSA-N
Molfile:
RDKit 2D
17 19 0 0 0 0 0 0 0 0999 V2000
12.4550 -12.6632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2766 -12.6632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8658 -11.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7213 -13.1782 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.4346 -12.7716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4346 -11.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7213 -11.5268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2228 -13.0241 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.0081 -12.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0081 -11.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2220 -11.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7413 -12.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3027 -13.7632 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1326 -13.7632 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1514 -11.5330 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5827 -11.5371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9662 -10.9084 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 3 1 0
2 1 1 0
3 2 1 0
10 7 1 0
8 9 1 0
10 11 1 0
11 12 2 0
12 8 1 0
9 4 1 0
4 13 2 0
4 5 1 0
4 14 2 0
5 6 2 0
6 15 1 0
15 3 1 0
6 7 1 0
3 16 1 0
9 10 2 0
11 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.24 | Molecular Weight (Monoisotopic): 334.9398 | AlogP: 2.12 | #Rotatable Bonds: 1 |
Polar Surface Area: 70.56 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.04 | CX Basic pKa: 1.34 | CX LogP: 1.86 | CX LogD: 1.86 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.82 | Np Likeness Score: -0.57 |
References
1. Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.. (2006) New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells., 49 (14): [PMID:16821773] [10.1021/jm060042j] |